In medical trial, a measles vaccine 'blitzkrieg' obliterated cancer

Thinkstock

In medical trial, a measles vaccine 'blitzkrieg' obliterated cancer
(Image credit: Thinkstock)

Willing to try anything to beat blood cancer, 50-year-old Stacy Erholtz decided to participate in a Mayo Clinic experimental trial that involved injecting enough measles vaccine to inoculate 10 million people. Now, thanks to that "measles blitzkrieg," the Minneapolis Star Tribune reports, almost a year later, Erholtz is in remission.

Erholtz's tumors were mostly in her bone marrow, while the other study participant had tumors in the leg muscles. While Erholtz was the only one who went into remission, the experiment provides the "proof of concept" that a large amount of intravenous viral therapy can wipe out cancer by overpowering its natural defenses. "It's a landmark," lead researcher Dr. Stephen Russell, a professor of molecular medicine, told the Star Tribune. "Nobody's shown that you can do that in people before."

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us
Catherine Garcia, The Week US

Catherine Garcia is night editor for TheWeek.com. Her writing and reporting has appeared in Entertainment Weekly and EW.com, The New York Times, The Book of Jezebel, and other publications. A Southern California native, Catherine is a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.